Intellia Therapeutics (NTLA) FCF Margin Growth (5y) (2020 - 2026)
Intellia Therapeutics (NTLA) FCF Margin Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Intellia Therapeutics | 1.32 Bn | 1.32 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,683.00 |
| Dec 31, 2025 | 32,298.00 |
| Sep 30, 2025 | -43,621.00 |
| Jun 30, 2025 | -105,436.00 |
| Mar 31, 2025 | -59,123.00 |
| Dec 31, 2024 | -43,254.00 |
| Sep 30, 2024 | -65,701.00 |
| Jun 30, 2024 | -55,669.00 |
| Mar 31, 2024 | -21,577.00 |
| Dec 31, 2023 | 446,080.00 |
| Sep 30, 2023 | -72,010.00 |
| Jun 30, 2023 | -39,601.00 |
| Mar 31, 2023 | -64,790.00 |
| Dec 31, 2022 | -19,616.00 |
| Sep 30, 2022 | -41,526.00 |
| Jun 30, 2022 | -32,024.00 |
| Mar 31, 2022 | -49,192.00 |
| Dec 31, 2021 | -9,861.00 |
| Sep 30, 2021 | -83,415.00 |
| Jun 30, 2021 | -245,342.00 |